MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	4.8	9.16	11.87
Short-Term Investments	48.34	34.01	29.84
Cash & Short-Term Investments	53.14	43.16	41.71
Cash Growth	23.12%	3.48%	-
Accounts Receivable	1.62	4.8	3.7
Other Receivables	1.11	1.51	1.44
Total Trade Receivables	2.73	6.31	5.14
Inventory	4.09	2.69	2.85
Total Current Assets	59.96	52.16	49.7
Net Property, Plant & Equipment	25.79	20.8	15.93
Other Intangible Assets	0.03	0.1	0.17
Other Long-Term Assets	0.47	0.44	0.67
Total Assets	86.26	73.5	66.46
Accounts Payable	7.65	5.28	5.53
Current Portion of Long-Term Debt	0.87	0.61	1.41
Other Current Liabilities	17.19	20.65	11.19
Total Current Liabilities	25.71	26.54	18.13
Long-Term Leases	8.15	6.51	6.35
Other Long-Term Liabilities	8.76	9.29	10.39
Total Long-Term Liabilities	16.92	15.8	16.74
Total Liabilities	42.62	42.34	34.86
Common Stock	0.26	0.22	0.18
Additional Paid-in Capital	272.33	236	206.25
Accumulated Other Comprehensive Income	-0.03	-0.01	-0.02
Retained Earnings	-228.93	-205.05	-174.82
Shareholders' Equity	43.63	31.15	31.6
Total Liabilities & Equity	86.26	73.5	66.46
Total Debt	9.02	7.13	7.76
Net Cash (Debt)	44.12	36.04	33.95
Net Cash Growth	22.43%	6.15%	-
Net Cash Per Share	3.88	3.62	3.77
Book Value	43.63	31.15	31.6
Book Value Per Share	3.84	3.13	3.51
Tangible Book Value	43.6	31.05	31.43
Tangible Book Value Per Share	3.83	3.12	3.49

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q